Occudo Quantitative Strategies LP Curis Inc Transaction History

Occudo Quantitative Strategies LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.57 - $0.99 $24,765 - $43,013	-43,448 Reduced 16.11%	226,213 $187,000
Q1 2023 May 15, 2023	SELL	$0.51 - $0.78 $3,666 - $5,608	-7,190 Reduced 2.6%	269,661 $161,000
Q4 2022 Feb 14, 2023	SELL	$0.47 - $17.22 $5,794 - $212,305	-12,329 Reduced 4.26%	276,851 $152,000
Q2 2022 Aug 15, 2022	BUY	$0.71 - $2.43 $1,065 - $3,647	1,501 Added 0.52%	289,180 $285,000
Q1 2022 May 16, 2022	BUY	$2.31 - $5.13 $346,490 - $769,479	149,996 Added 108.94%	287,679 $685,000
Q4 2021 Feb 14, 2022	BUY	$4.45 - $8.09 $612,689 - $1.11 Million	137,683 New	137,683 $655,000
Q1 2021 May 14, 2021	SELL	$8.78 - $12.8 $167,399 - $244,044	-19,066 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$1.08 - $8.2 $20,591 - $156,341	19,066 New	19,066 $156,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.